These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 1561416)

  • 21. [Metabolic characterization of ovarian tumors with positron-emission tomography and F-18 fluorodeoxyglucose].
    Römer W; Avril N; Dose J; Ziegler S; Kuhn W; Herz M; Jänicke F; Schwaiger M
    Rofo; 1997 Jan; 166(1):62-8. PubMed ID: 9072107
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cerebral necrosis after radiotherapy and/or intraarterial chemotherapy for brain tumors: PET and neuropathologic studies.
    Di Chiro G; Oldfield E; Wright DC; De Michele D; Katz DA; Patronas NJ; Doppman JL; Larson SM; Ito M; Kufta CV
    AJR Am J Roentgenol; 1988 Jan; 150(1):189-97. PubMed ID: 3257119
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Whole-body PET with (fluorine-18)-2-deoxyglucose for detecting recurrent ovarian carcinoma. Initial report.
    Yuan CC; Liu RS; Wang PH; Ng HT; Yeh SH
    J Reprod Med; 1999 Sep; 44(9):775-8. PubMed ID: 10509300
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Value of 18F-FDG and 11C-MET PET-CT in differentiation of brain ringlike-enhanced neoplastic and non-neoplastic lesions on MRI imaging].
    Cai L; Gao S; Li DC; Li YS; Chen QS; Xing XL
    Zhonghua Zhong Liu Za Zhi; 2009 Feb; 31(2):134-8. PubMed ID: 19538892
    [TBL] [Abstract][Full Text] [Related]  

  • 25. FDG-PET in differentiating lymphoma from nonmalignant central nervous system lesions in patients with AIDS.
    Hoffman JM; Waskin HA; Schifter T; Hanson MW; Gray L; Rosenfeld S; Coleman RE
    J Nucl Med; 1993 Apr; 34(4):567-75. PubMed ID: 8455072
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 18-fluorodeoxyglucose positron emission tomography enhances computed tomography diagnosis of malignant intraductal papillary mucinous neoplasms of the pancreas.
    Sperti C; Bissoli S; Pasquali C; Frison L; Liessi G; Chierichetti F; Pedrazzoli S
    Ann Surg; 2007 Dec; 246(6):932-7; discussion 937-9. PubMed ID: 18043094
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhanced detectability of recurrent brain tumor using glucose-loading F-18 FDG PET.
    Seo YS; Chung TW; Kim IY; Bom HS; Min JJ
    Clin Nucl Med; 2008 Jan; 33(1):32-3. PubMed ID: 18097254
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Monitoring liver tumor therapy with [18F]FDG positron emission tomography.
    Nagata Y; Yamamoto K; Hiraoka M; Abe M; Takahashi M; Akuta K; Nishimura Y; Jo S; Masunaga S; Kubo S
    J Comput Assist Tomogr; 1990; 14(3):370-4. PubMed ID: 2335602
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PET scans of abdominal malignancy.
    Blahd WH; Brown CV; Khonsary SA; Farahi JB; Quinones N; Ribe JY; Coyle JJ; Glass EC; Mandelkern MA
    World J Surg; 1996 Feb; 20(2):245-7. PubMed ID: 8661826
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 18-Fluorodeoxyglucose uptake and survival of patients with suspected recurrent malignant glioma.
    Barker FG; Chang SM; Valk PE; Pounds TR; Prados MD
    Cancer; 1997 Jan; 79(1):115-26. PubMed ID: 8988735
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical application of PET for the evaluation of brain tumors.
    Coleman RE; Hoffman JM; Hanson MW; Sostman HD; Schold SC
    J Nucl Med; 1991 Apr; 32(4):616-22. PubMed ID: 2013802
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recurrent rectal cancer and scar: differentiation with PET and MR imaging.
    Ito K; Kato T; Tadokoro M; Ishiguchi T; Oshima M; Ishigaki T; Sakuma S
    Radiology; 1992 Feb; 182(2):549-52. PubMed ID: 1732979
    [TBL] [Abstract][Full Text] [Related]  

  • 33. FDG hypermetabolism associated with inflammatory necrotic changes following radiation of meningioma.
    Fischman AJ; Thornton AF; Frosch MP; Swearinger B; Gonzalez RG; Alpert NM
    J Nucl Med; 1997 Jul; 38(7):1027-9. PubMed ID: 9225785
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stereotactic brain biopsy guided by positron emission tomography (PET) with [F-18]fluorodeoxyglucose and [C-11]methionine.
    Pirotte B; Goldman S; David P; Wikler D; Damhaut P; Vandesteene A; Salmon L; Brotchi J; Levivier M
    Acta Neurochir Suppl; 1997; 68():133-8. PubMed ID: 9233429
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recurrent tumor vs radiation effects after gamma knife radiosurgery of intracerebral metastases: diagnosis with PET-FDG.
    Mogard J; Kihlström L; Ericson K; Karlsson B; Guo WY; Stone-Elander S
    J Comput Assist Tomogr; 1994; 18(2):177-81. PubMed ID: 8126264
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical value of PET with 18F-fluorodeoxyglucose and L-methyl-11C-methionine for diagnosis of recurrent brain tumor and radiation injury.
    Ogawa T; Kanno I; Shishido F; Inugami A; Higano S; Fujita H; Murakami M; Uemura K; Yasui N; Mineura K
    Acta Radiol; 1991 May; 32(3):197-202. PubMed ID: 2064862
    [TBL] [Abstract][Full Text] [Related]  

  • 37. (18) F-fluorodeoxyglucose positron emission tomography/computed tomography for the detection of recurrent bone and soft tissue sarcoma.
    Al-Ibraheem A; Buck AK; Benz MR; Rudert M; Beer AJ; Mansour A; Pomykala KL; Haller B; Juenger H; Scheidhauer K; Schwaiger M; Herrmann K
    Cancer; 2013 Mar; 119(6):1227-34. PubMed ID: 23233156
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of response to cancer therapy using fluorine-18-fluorodeoxyglucose and positron emission tomography.
    Ichiya Y; Kuwabara Y; Otsuka M; Tahara T; Yoshikai T; Fukumura T; Jingu K; Masuda K
    J Nucl Med; 1991 Sep; 32(9):1655-60. PubMed ID: 1880564
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differentiation of cerebral radiation necrosis from tumor recurrence by [18F]FDG and 82Rb positron emission tomography.
    Doyle WK; Budinger TF; Valk PE; Levin VA; Gutin PH
    J Comput Assist Tomogr; 1987; 11(4):563-70. PubMed ID: 3496366
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of pancreatic tumors with positron emission tomography and F-18 fluorodeoxyglucose: comparison with CT and US.
    Inokuma T; Tamaki N; Torizuka T; Magata Y; Fujii M; Yonekura Y; Kajiyama T; Ohshio G; Imamura M; Konishi J
    Radiology; 1995 May; 195(2):345-52. PubMed ID: 7724751
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.